Carl M, Alms A, Braun J, Dongas A, Erb J, Goetz A, Goepfert M, Gogarten W, Grosse J, Heller A R, Heringlake M, Kastrup M, Kroener A, Loer S A, Marggraf G, Markewitz A, Reuter D, Schmitt D V, Schirmer U, Wiesenack C, Zwissler B, Spies C
Department of Anesthesiology and Intensive Care, Charité University Medicine Berlin, Charité Campus Mitte and Campus Virchow Klinikum, Berlin, Germany.
Ger Med Sci. 2010 Jun 15;8:Doc12. doi: 10.3205/000101.
Hemodynamic monitoring and adequate volume-therapy, as well as the treatment with positive inotropic drugs and vasopressors are the basic principles of the postoperative intensive care treatment of patient after cardiothoracic surgery. The goal of these S3 guidelines is to evaluate the recommendations in regard to evidence based medicine and to define therapy goals for monitoring and therapy. In context with the clinical situation the evaluation of the different hemodynamic parameters allows the development of a therapeutic concept and the definition of goal criteria to evaluate the effect of treatment. Up to now there are only guidelines for subareas of postoperative treatment of cardiothoracic surgical patients, like the use of a pulmonary artery catheter or the transesophageal echocardiography. The German Society for Thoracic and Cardiovascular Surgery (Deutsche Gesellschaft für Thorax-, Herz- und Gefässchirurgie, DGTHG) and the German Society for Anaesthesiology and Intensive Care Medicine (Deutsche Gesellschaft für Anästhesiologie und lntensivmedizin, DGAI) made an approach to ensure and improve the quality of the postoperative intensive care medicine after cardiothoracic surgery by the development of S3 consensus-based treatment guidelines. Goal of this guideline is to assess the available monitoring methods with regard to indication, procedures, predication, limits, contraindications and risks for use. The differentiated therapy of volume-replacement, positive inotropic support and vasoactive drugs, the therapy with vasodilatators, inodilatators and calcium sensitizers and the use of intra-aortic balloon pumps will also be addressed. The guideline has been developed following the recommendations for the development of guidelines by the Association of the Scientific Medical Societies in Germany (AWMF). The presented key messages of the guidelines were approved after two consensus meetings under the moderation of the Association of the Scientific Medical Societies in Germany (AWMF).
血流动力学监测和充分的容量治疗,以及使用正性肌力药物和血管升压药进行治疗,是心胸外科手术后患者术后重症监护治疗的基本原则。这些S3指南的目的是评估基于循证医学的建议,并确定监测和治疗的目标。结合临床情况,对不同血流动力学参数的评估有助于制定治疗方案,并确定评估治疗效果的目标标准。到目前为止,针对心胸外科手术患者术后治疗的各个子领域仅有一些指南,如肺动脉导管的使用或经食管超声心动图检查。德国胸心血管外科学会(Deutsche Gesellschaft für Thorax-, Herz- und Gefässchirurgie, DGTHG)和德国麻醉与重症医学学会(Deutsche Gesellschaft für Anästhesiologie und lntensivmedizin, DGAI)通过制定基于S3共识的治疗指南,致力于确保和提高心胸外科手术后重症监护医学的质量。本指南的目的是评估现有监测方法在适应证、操作、预测、局限性、禁忌证和使用风险方面的情况。还将探讨容量替代、正性肌力支持和血管活性药物的差异化治疗,血管扩张剂、心肌收缩性扩张剂和钙敏化剂的治疗以及主动脉内球囊泵的使用。本指南是按照德国科学医学协会联合会(AWMF)制定指南的建议编写的。本指南所呈现的关键信息在德国科学医学协会联合会(AWMF)主持的两次共识会议后获得批准。